Cost-effectiveness of new drugs in patients with phase IIIB-IV non-small lung cancer: Results of a Markov chain model

Carin Uyl - de Groot, J Mcdonnell, HJM Groen, D Radice, G Velde

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)37-41
Number of pages5
JournalEuropean Journal of Hospital Pharmacy Science
Volume2
Publication statusPublished - 2005

Cite this